Blog - Page 3020 of 5587

WednesdayNov 21, 2012 5:58 pm

TNI BioTech, Inc. (TNIB) Goes After the Magic Bullet

TNI BioTech is combating fatal diseases by using the developing science of immunotherapy. By learning how to activate and manipulate the body’s own immune system, TNI has developed their own patented immunotherapy that promises new and better options for the treatment of cancer and infections such as HIV and autoimmune diseases. TNI’s most advanced clinical programs involve immunotherapy that isolates a patient’s lymphocytes and then incubates them together with Methionine Enkephalin (MENK). The lymphocytes are then reinfused back into the patient where they combat and destroy tumor cells. A primary target for immunotherapy is cancer, and it’s an approach that…

WednesdayNov 21, 2012 5:57 pm

Green Innovations Ltd. (GNIN) Acquires “Sensational” Trademark to Expand Product Offerings Nationwide

Green Innovations, via its wholly owned subsidiary, Green Hygienics, has acquired the “Sensational” trademark from Texas-based Sensational Brands (SBI-TX), a distributor of specialty branded and private label bathroom tissue, paper napkins, paper towels, and wipes. Per the deal, Green Hygienics will manufacture and distribute its non-green product lines under the Sensational trademark through its new Florida subsidiary, Sensational Brands (SBI-FL). The acquisition corresponds with Green Innovation’s dedication to producing eco-friendly goods derived from bamboo products. “The acquisition of the ‘Sensational’ trademark is strategically important as it provides us with an established brand which complements the company’s current line of green…

WednesdayNov 21, 2012 5:56 pm

Ivanhoe Energy, Inc. (IVAN) Sells Pan-China, Shifts to Focus on Core Heavy Oil Assets Supporting HTL Technology Commercialization

Ivanhoe Energy, the independent international heavy oil E&P with primary operations in Canada and the U.S., as well as Ecuador, China, and Mongolia, focused on pushing the envelope through their patented heavy oil upgrading HTL Process (heavy-to-light), reported today that the company has signed an important share purchase and sale agreement with MIE Holdings for all outstanding shares of the company’s indirect, wholly-owned Pan-China Resources Ltd. subsidiary, for a total of $45M in cash (effective Sept 30). This deal is a huge win for IVAN and is perfectly in-line with the company’s renewed strategy, a strategy that includes priorities like…

TuesdayNov 20, 2012 6:08 pm

Stay Informed with the QualityStocks Blog!

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them. One of our most popular ways, the QualityStocks Blog, keeps investors up to date on everything related to the Small-Cap and Micro-Cap markets. Alternative fuels and power sources, entertainment media, telecommunications, delivery services, healthcare, and retail are all covered…

TuesdayNov 20, 2012 6:07 pm

NeoStem, Inc. (NBS) Receives Two-Year $1.2 Million NIH Grant for First Clinical Study of VSEL Technology in Humans

NeoStem is a firm engaged in the fast growing cell therapy industry. This industry is expected to have a significant role in the future in the fight against chronic disease. The company’s contract development and manufacturing service business, Progenitor Cell Therapy LLC, supports the development of proprietary cell therapy products. The company today announced that it has been awarded a two-year grant totaling $1,221,854 from the National Institute of Dental and Craniofacial Research, a division of the National Institute of Health (NIH). The grant was for “Repair of Bone Defects With Human Autologous Pluripotent Very Small Embryonic-Like Stem Cells (VSEL)”.…

TuesdayNov 20, 2012 6:06 pm

Axxess Unlimited (AXXU) Strengthens Leading Position in Interlock Market with New Mobile App

Axxess Unlimited, an emerging data flow management and digital marketing company focused on large market opportunities, recently announced the introduction of its first ignition interlock mobile application, the Axxess Information Reporting (AIR) app. Now available through Apple for the iPhone and iPad, this app will soon be launched on the Android market as well. Featuring an intuitive interface and up-to-date information, the AIR app includes a breath alcohol calculator (BAC) to prevent those with an interlock from violating their restricted driving privilege, a sales and service locator, the company’s “Connect to Cab” feature, and the previously announced “Refer a Friend”…

TuesdayNov 20, 2012 6:03 pm

Ohr Pharmaceutical, Inc. (OHRP) Appoints Two New Members to Scientific Advisory Board

Ohr Pharmaceutical has expanded its Scientific Advisory Board (SAB) with the addition of two prominent ophthalmologists who will join the current panel of retinal ophthalmology experts focused on advancing the company’s Squalamine eye drop program into clinical efficacy trials. David S. Boyer, M.D. of Retina-Vitreous Associates Medical Group in Los Angeles and Lawrence J. Singerman, M.D. of Retina Associates of Cleveland were appointed to Ohr Pharmaceutical’s SAB to advise the company on its clinical programs, regulatory strategy, and to provide strategic guidance to support the development of Squalamine. “We are pleased to be working with thought leaders in the retina…

MondayNov 19, 2012 6:19 pm

Cardium Therapeutics, Inc. (CXM) Wins IP Protection for Cardiovascular Gene Therapy

Cardium Therapeutics, an asset-based health sciences and regenerative medicine company, today announced it was on the winning side of a patent decision made in Europe. This decision resolved a long-standing competition between Cardium and its licensor the University of California, and Boston Scientific (NYSE: BSX) and its licensor Arch Development, over rights to key methods for the application of cardiovascular gene therapy to the treatment of coronary heart disease. Cardium’s Generx® gene therapy candidate, which employs these key methods, is currently in late-stage clinical studies. Cardium’s patent portfolio now includes allowed and issued patents covering its gene therapy approach both…

MondayNov 19, 2012 6:18 pm

DoMark International, Inc. (DOMK) Subsidiary Launches New Website to Promote Infrared/Solar Apple Accessories

SolaWerks, a subsidiary of DoMark International primarily focused on infrared/solar charging systems for Apple devices, announced the launch of a brand new website, IRcharger.com. Today’s news comes shortly after last week’s announcement introducing SolaWerks’ innovative, patent-pending INFRASOL technology, which utilizes infrared energy to power the latest Apple iPads and iPhones. IRcharger.com will help the company increase awareness of the most cutting-edge, most environmentally friendly, and most cost effective mobile device charging system available. The new website was developed to offer the user easier navigation, educational tools, and a more enjoyable experience while shopping for INFRASOL-enabled SolaWerks cover/charger systems. IRcharger.com was…

MondayNov 19, 2012 6:17 pm

VIASPACE, Inc. (VSPC) Engages QualityStocks Investor Relations Services

VIASPACE just announced that they have agreed with QualityStocks to be featured in The Small Cap QualityStocks Daily Newsletter, QualityStocks Daily Blogs, and Message Boards. QualityStocks, based in Scottsdale, Arizona, is a free service that collates data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts. VIASPACE is focused on growing renewable Giant King™ Grass as a low-carbon fuel for clean electricity generation and environmentally friendly energy pellets, as well as a feedstock for bio-methane production, green cellulosic biofuels, biochemical, and biomaterials.…

Site Search

Company Search